Agenda
Friday, June 21, 2024
IBD
8:30–8:35 AM
Welcome to GI ReConnect 2024
Stephen B. Hanauer, MD
8:35–8:55 AM
Biomarkers & Wearables to Track Disease
& Response
Aline Charabaty, MD, AGAF, FACG
9:00–9:20 AM
Will AI Change Our Approach to Mucosal Healing?
Ryan Stidham, MD, MSc
9:25–9:45 AM
Current & Future Utility of IBUS for
Disease Monitoring
Rishika Chugh, MD
9:50–10:10 AM
Will Someone Define What Is
Moderate-Severe Disease?
10:10–10:25 AM
Q&A
10:25–10:40 AM
Break
10:40–11:00 AM
Selecting First Line Advanced Therapies for UC
Gary Lichtenstein, MD
11:05–11:25 AM
Selecting First Line Advanced Therapies for CD
11:30–11:50 AM
Playing JAKs: Right Patient, Right Time, Right Dose
Russell D. Cohen, MD
11:55 AM–12:15 PM
Combining Therapies for IBD: Rationale and
Practical Aspects
Maria T. Abreu, MD
12:15–12:30 PM
Q&A
Saturday, June 22, 2024
Novel Diagnostic Approaches
8:30–8:35 AM
Welcome Back
Darren M. Brenner, MD
8:35–8:55 AM
FDA Endpoints for Gastroparesis
Anthony Lembo, MD
8:55–9:15 AM
Novel Capsule Technologies for DGBI and Motility Disorders
Baharak Moshiree, MD
9:15–9:35 AM
Novel Breath Testing Technologies
9:35–9:55 AM
When It's Not IBS
Darren M. Brenner, MD
9:55–10:10 AM
Q&A
10:10–10:35 AM
Break
Update on Therapeutics
10:35–10:55 AM
Eosinophilic GI Disorders
Evan S. Dellon, MD, MPH
10:55–11:15 AM
ACG Clinical Practice Guideline on H. pylori
Wiliam D. Chey, MD
11:15–11:35 AM
Update on C. difficile
Colleen Kelly, MD
11:35–11:55 AM
Microbiome-Based Therapies
Mark Pimentel, MD
11:55 AM–12:15 PM
Update on Treatments for IBS-C and CIC
Lin Chang, MD
12:15–12:30 PM
Q&A